$7.290
-0.060 (-0.82%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
ATAI 相似图表分析预测
Alphio's ATAI stock price prediction model matches the current AtaiBeckley Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $7.34 (+0.67%). The 1-week path is $7.15 (-1.94%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 AtaiBeckley Inc 股票吗?
ATAI Life Sciences NV is not a good buy right now, as the current price of $7.29 is above the downgraded analyst price targets of $7.50 and $8. The stock has experienced a significant decline in analyst ratings due to the pending acquisition by Eli Lilly, which offers a cash payment of $6.75 per share plus contingent payments. Furthermore, the RSI is at 40.989, indicating a lack of momentum for a potential upward move, and the recent 5-day change is down by 1.22%.
ATAI 股价于 Friday 收于 $7.29,此前下跌 -0.82%
AtaiBeckley Inc (ATAI) last closed at $7.29, losing -0.82%. These facts feed the 1-day and 1-week ATAI price prediction above.
预测驱动因素
AtaiBeckley Inc(ATAI)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
相似图表形态
近期走势与 ATAI 最接近的股票,按相似度排序。
ATAI 季节性分析
Historically the probability of a positive August return for ATAI is 65.62%. February offers the highest probability of a positive month at 79.31%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。